Author: healthadmin

An experimental drug has been shown to reduce Huntington’s disease symptoms and extend lifespan in a mouse model. Further research is needed to determine whether these results also apply to humans. Huntington’s disease, a genetic disease, was previously thought to be incurable. Its clinical symptoms include motor control disorders and psychiatric symptoms. New research offers promising insights. This shows that a particular drug candidate, called anle138b, can significantly reduce the clumps of toxic proteins in the brain that are a hallmark of the disease. Affected mice treated with the compound remained motile for longer, had less brain shrinkage, and had…

Read More

Research published in onco target highlights a promising new approach to combating pancreatic cancer. The paper, titled “The anticancer effects of PCAI in pancreatic cancer cells involves hyperactivation of the MAPK and PI3K/AKT pathways,” was led by first author Kweku Ofosu-Asante and corresponding author Nazarius S. Lamango of the Florida A&M University College of Pharmacy and Department of Pharmaceutical Science at the Institute of Public Health in Tallahassee, Florida. Pancreatic ductal adenocarcinoma is one of the most deadly cancers. The main reason is the high prevalence of KRAS mutations, which promote tumor growth and often make tumors difficult to treat.…

Read More

Working from home can bring unexpected challenges to relationships, and in some cases increases the likelihood that couples will consider breaking up. Psychological evaluations show evidence that when remote workers and their partners disagree about separating work and home, the resulting stress can foster deep feelings of loneliness. These research results have recently organizational behavior journal. To understand how remote work impacts couples, it’s helpful to focus on a concept known as segmentation preferences. This term describes a person’s psychological desire to protect their personal life from work-related interruptions. Some people have a strong preference for segmentation. They prefer to…

Read More

Researchers warn that using screens during the first 1,001 days of life could lead to developmental concerns in the next generation. Digital screen time in children under two years of age is associated with long-term effects and limited benefits on health and quality of life, according to the most comprehensive systematic review to date of global peer-reviewed research on screen time in infants, published today (Saturday 27 June). This affects an entire generation and the quality of life in the future. Leif Clayton, School of Media and Communication Based on the findings, the iADDICT group, made up of…

Read More

Diabetic patients who contract COVID-19 tend to recover more slowly, experience complications of COVID-19 for longer, have a lower quality of life, and require closer and longer-term monitoring by their medical team. This was demonstrated in a University of São Paulo study that followed 870 people for up to seven months after hospitalization. The study was published in the journal scientific report. Diabetes is not only a risk factor for the acute phase of COVID-19 infection. It has also been shown to prolong recovery time and impair quality of life in the long term. This study makes it abundantly…

Read More

Some U.S. lawmakers are rushing to introduce legislation that would reverse the impact of a U.S. Supreme Court decision handed down last week that overturned longstanding precedent restricting consumer lawsuits against pesticide companies. Democratic Rep. Chellie Pingree of Maine and Republican Rep. Thomas Massie of Kentucky on Monday introduced amendments to the federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the key law regulating pesticides. The FIFRA amendments would allow people exposed to pesticides known to cause health problems to once again sue companies for failing to warn them about the health risks. The Supreme Court’s decision most directly benefited Bayer…

Read More

Researchers have created a powerful new cell model to study rare tumors that are resistant to immunotherapy. This tool could change the way treatments are developed for melanoma, for which there are currently few effective treatment options. A research team at the University of Turku in Finland has developed a reliable laboratory model to study BAP1-deficient melanoma. BAP1-deficient melanoma is a rare type of melanoma that evades the immune system once it metastasizes and is universally resistant to current state-of-the-art immunotherapies.Metastatic BAP1-deficient melanoma is the most common intraocular malignancy in adults, but it remains rare and extremely difficult to treat…

Read More

New research published in 2006 shows that older adults discharged from the hospital with new prescriptions for sedatives, especially benzodiazepines and antipsychotics, are at increased risk of falls and other negative outcomes. CMJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251965. ”Our results showed that discharging older adults after admission to an acute hospital with a new prescription for these drugs is associated with an increased risk of falls requiring medical attention, need for further acute hospital treatment, and death in the 30 days after discharge, whereas previously exposed individuals did not see a similar increased risk.,” wrote Dr. Lisa Barry, a clinical…

Read More

A new study commissioned by The Ohio State University Wexner Medical Center finds that young people are missing out on the health benefits of having a primary care physician. A national poll of 1,006 adults found that only 71% of adults aged 18 to 29 have a family doctor, compared to 97% of adults aged 65 and older. Only 47% of young people who see a doctor have had a health check in the past year. Having a primary care physician is especially important when you are young. We’re looking five, 10, 20 years out. That’s because it’s the…

Read More

Canada recently approved lecanemab for the treatment of early-stage Alzheimer’s disease, but the clinical benefit is modest, there is a risk of serious side effects, and the treatment is complex. article CMJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260193 Provides an overview of medications and advises healthcare professionals to share decisions with patients and caregivers so they understand potential risks and benefits. ”Interpretation of the benefits of lecanemab may be influenced by the limited availability of treatments for Alzheimer’s disease and the personal and societal burden of Alzheimer’s disease. Clinical benefits are modest at best, and effects on quality of life, independence,…

Read More